Why the study?
Low-grade inflammation and arterial stiffness are key factors in vascular aging, but their interplay in cardiovascular disease remains unclear.
Do arterial stiffness and systemic inflammation have an additive or mediating effect on cardiovascular disease risk in elderly participants?
Do arterial stiffness and systemic inflammation have an additive or mediating effect on cardiovascular disease risk in elderly participants?
Arterial stiffness and chronic inflammation appear to affect cardiovascular risk through separate, additive causal pathways rather than arterial stiffness acting as a mediator for inflammation.
Suggests additive rather than mediated effects on CV risk; leaves open whether dual pathway targeting improves outcomes in the elderly.
Low-grade inflammation and arterial stiffness are key factors in the development of vascular aging. However, the interplay between arterial stiffness and inflammation for cardiovascular (CV) disease is unclear. Aortic pulse wave velocity (aPWV) and the inflammatory markers, high-sensitivity C-reactive protein (CRP) and orosomucoid, were measured in 2710 participants (median age: 72 years). These participants were followed up for a mean of 7.6 years for a composite CV disease end point. Per 1 interquartile range increment of CRP and orosomucoid, respectively, aPWV increased by 0.19 m/s (95% CI: 0.07-0.32) and 0.19 m/s (0.11-0.27), after multifactorial adjustment. Mediation analysis showed that aPWV, after multifactorial adjustment, mediated 8% (-4, 20) of the CV disease risk associated with CRP and 8% (-4, 18) of orosomucoid risk. The associated risk increased with combinations of high aPWV and high CRP or orosomucoid. We found no evidence that arterial PWV acted as an important mediator of the relationship between systemic inflammation and CV disease risk in this elderly population. The results instead indicate an additive effect. Our study supports the view that arterial stiffness and chronic inflammation affects CV risk mainly through separate causal pathways.
No takes yet. Share an insight, caveat, or question.
Wadström et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: